Press Releases

NEW YORK, July 11, 2019 /PRNewswire/ -- A new report from WebMD finds that while grief is nearly universal, most people feel rushed to "get over it," and find social media posts about their loss among the least helpful responses from others during the grieving process.

Read more...

NEW YORK, July 11, 2019 /PRNewswire/ -- LabFinder.com, the convenient online platform for patients to schedule their laboratory and radiology tests and access test results, has announced an API in

Read more...

EXTON, Pa., July 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it

Read more...

MONTGOMERY, Ala., July 11, 2019 /PRNewswire/ -- H2-Pharma, LLC, a privately held pharmaceutical company, announced today that it has entered into an agreement with CHEPLAPHARM Arzneimittel GmbH to be the exclusive U.S. distributor of ETOPOPHOS® (etoposide phosphate) for injection. This opportunity arose due to its successful partnership with CHEPLAPHARM Arzneimittel

Read more...

PHILADELPHIA, July 11, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global healthcare company, today highlighted the first publication of National Comprehensive Cancer Network (NCCN) pediatric acute lymphoblastic leukemia (ALL)

Read more...

SOUTH SAN FRANCISCO, Calif., July 11, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announces initiation of its Phase 1/2 study evaluating IDE196 in Patients with Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions (ClinicalTrials

Read more...

SLOUGH, England and RICHMOND, Va., July 11, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced revised expectations for FY 2019 net revenue and net income following stronger than expected H1 2019 net revenue performance.  The primary driver has been the market share outperformance of its branded SUBOXONE® (buprenorphine and naloxone)

Read more...

Second quarter 2020 revenue of $14.6 million, an increase of 18% over prior yearGross margin improved to 33.5%Net income of $1 million, earnings per share of $0.06 and EBITDA of $1.5 million for the second quarter 2020Unused medications billings grew 72%

Read more...

BRENTWOOD, Tenn., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (OTCQX: DVCR), a premier provider of long-term care services, today announced that the American Health Care Association (AHCA) and National Center for Assisted Living (NCAL) recognized 51 Diversicare centers for their achievements in the quality of care they provide. 

Read more...

MINNEAPOLIS, Jan. 28, 2020 (GLOBE NEWSWIRE) --  NovuHealth, the healthcare industry’s leading consumer engagement company, today announced its new Member

Read more...